| 注册
首页|期刊导航|中国临床药理学杂志|不同剂量瑞马唑仑用于颅内动脉瘤血管介入术麻醉的临床研究

不同剂量瑞马唑仑用于颅内动脉瘤血管介入术麻醉的临床研究

郑德利 王巨增 陈欢 李慧利 史记 孟莉

中国临床药理学杂志2024,Vol.40Issue(13):1860-1864,5.
中国临床药理学杂志2024,Vol.40Issue(13):1860-1864,5.DOI:10.13699/j.cnki.1001-6821.2024.13.003

不同剂量瑞马唑仑用于颅内动脉瘤血管介入术麻醉的临床研究

Clinical trial on vascular intervention anesthesia of intracranial aneurysms using different doses of remimazolam

郑德利 1王巨增 2陈欢 1李慧利 1史记 1孟莉3

作者信息

  • 1. 河北医科大学第一医院麻醉科,河北石家庄 050000
  • 2. 河北医科大学第一医院介入治疗科,河北石家庄 050000
  • 3. 河北医科大学第一医院神经内科,河北石家庄 050000
  • 折叠

摘要

Abstract

Objective To explore the application effect and safety of general anesthesia with different doses of remimazolam during vascular intervention anesthesia of intracranial aneurysms.Methods Patients with intracranial aneurysms were divided into high,middle and low dose groups according to the random number table method.The venous access was opened after the patients entered the room,and the vital signs were closely monitored.The low,middle and high dose groups were intravenously injected with 0.25,0.30 and 0.35 mg·kg-1remazolam,respectively.After the loss of consciousness,alfentanil and mivacurium chloride were given for anesthesia induction.The anesthetic effect,recovery quality,hemodynamic indexes,cerebral hemodynamic indexes and neurological function indexes before anesthesia induction(T0),at the time of laryngeal mask insertion(T1),embolization(T2),5 min after operation(T3)and 30 min after operation(T4)were compared among the three groups.The incidence of postoperative cerebral vasospasm(CVS),delayed ischemic neurological dysfunction(DIND)and the incidence of adverse drug reactions related to anesthesia were counted.Results The onset times of anesthesia in the high,middle,and low dose groups were(5.03±1.28),(5.17±1.09),and(7.21±1.15)min,respectively;the number of anesthesia rescue interventions were(0.12±0.02),(0.21±0.06),and(1.51±0.23)times,respectively.There was statistically significant difference in the number of rescue interventions between the high and middle dose groups compared to the low dose group(all P<0.05).The therapeutic efficacy rates of flumazenil in the high,middle,and low dose groups were 18.18%,11.11%and 2.86%,respectively.the mean arterial pressure(MAP)at T2 were(87.06±6.02),(86.85±5.61)and(81.09±5.37)mmHg;the MAP at T4 were(92.05±5.13),(87.57±6.29)and(84.42±5.16)mmHg,respectively.There was statistically significant difference in MAP between the high and low dose groups(all P<0.05).There were no statistically significant differences in heart rate(HR),oxygen saturation(SpO2),left peak systolic velocity of middle cerebral artery(Vp-MCA),left mean systolic velocity of middle cerebral artery(Vm-MC)and pulsatility index(PI),S100β protein,and neuron-specific enolase(NSE)levels among the three groups at different time points(all P>0.05).There were no statistically significant differences in the incidence rates of cardiovascular system complications,delayed postoperative cognitive dysfunction,or anesthesia-related adverse reactions between the three groups(all P>0.05).Conclusion The safety of different doses of remimazolam general anesthesia in the vascular interventional therapy of intracranial aneurysms is high,and the effects on cerebral hemodynamics and neurological function are similar.However,high-dose remimazolam have shorter general anesthesia induction time and less intraoperative anesthesia remedy frequency while the high-dose remimazolam has higher postoperative flumazenil antagonist therapy.

关键词

瑞马唑仑/用药剂量/麻醉/氟马西尼拮抗治疗/颅内动脉瘤/脑血流动力学/神经功能/安全性

Key words

remimazolam/medication dosage/anesthesia/flumazenil antagonist therapy/intracranial aneurysms/cerebral hemodynamics/neurological function/safety

分类

药学

引用本文复制引用

郑德利,王巨增,陈欢,李慧利,史记,孟莉..不同剂量瑞马唑仑用于颅内动脉瘤血管介入术麻醉的临床研究[J].中国临床药理学杂志,2024,40(13):1860-1864,5.

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文